April is Parkinson鈥檚 Awareness Month
Multidisciplinary care and cutting-edge research share space at The NeuroThe Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson鈥檚 disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties.
Improving memory with magnets
Discovery expands our understanding of how we remember soundThe ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives 鈥 without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.
Epilepsy Day 2017
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide
Dr. Computer
Deep learning transforming neuroscience researchIn an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute鈥檚 McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.
Health Science Leaders Join Forces to Accelerate Development of Treatments for Neurological Diseases
Montreal, Quebec and Vancouver, British Columbia 鈥 Working together to accelerate research into neurological diseases, three leading players in Canada鈥檚 health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig鈥檚 disease, and Parkinson鈥檚 disease.
Molecule shown to repair damaged axons
Discovery could be key to treating brain and spinal cord injuryA foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.
Recognizing rare diseases
Research and clinical care complement each other at The Neuro
February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.
MNI scientist receives $1.5M grant for Parkinson's/ALS research
CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research
Bell Let鈥檚 Talk supports mental health with The Neuro
Project will enhance mental health access for multicultural communities
On Jan. 18, 2017, Bell Let鈥檚 Talk announced a donation of $250,000 to 捆绑SM社区鈥檚 Montreal Neurological Institute and Hospital 鈥 known as The Neuro 鈥 to fund the development of online mental health resources focused on the needs of multicultural communities.
HEADS UP On The Concussion Issue to raise awareness of head injury
An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.
Lack of joy from music linked to brain disconnection
Have you ever met someone who just wasn鈥檛 into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.
Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of 捆绑SM社区 have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.
Breakthrough in MS treatment
Drug shown to reduce new attacks/symptom progression in some patients
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.
The Neuro holds annual Reitman Holiday Luncheon
Each December for over 60 years, the Reitman family has invited all members of The Neuro to a splendid luncheon that has become an enjoyable annual tradition. This gathering shows a wonderful holiday spirit of generosity and thankfulness.
How HIV affects the brain
Study tracks patients to better understand effects and possible treatments
December 1 is World AIDS Day, a time to raise awareness about a disease that has afflicted 70 million people worldwide, 35 million of whom have died as a result.
Epileptic encephalopathy linked to protein trafficking gene
Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells.